Research Article
A Five-Gene Signature for Recurrence Prediction of Hepatocellular Carcinoma Patients
Table 1
Demographic characteristics of HCC patients.
| | Clinical and pathological variable | GSE14520 () | GSE76427 () |
| | Gender (male/female) | 161/29 | 79/21 | | Age (years) | | | | AVR-CC (no/yes/NA) | 132/53/5 | NA | | ALT (<=50 U/l/>50 U/l) | 117/73 | NA | | Main tumor size (<=5 cm/>5 cm/NA) | 133/56/1 | NA | | Multinodular (no/yes) | 157/33 | NA | | Cirrhosis (no/yes) | 16/174 | NA | | TNM stage (I-II/III-IV/NA) | 168/22/0 | 85/14/1 | | CLIP stage(0/1/2/3) | 94/70/25/1 | NA | | BCLC stage (0/A/B) | 20/148/22 | 4/71/25 | | AFP (<=300 ng/ml/>300 ng/ml/NA) | 108/79/3 | NA |
|
|
Abbreviations: AVR-CC: active viral replication chronic carrier; ALT: alanine aminotransferase; TNM: tumor node metastasis; CLIP: cancer liver Italian program; BCLC: Barcelona Clinic Liver Cancer; AFP: alpha-fetoprotein.
|
